| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |